Home
GSC Biological and Pharmaceutical Sciences
Peer-reviewed Journal | Impact factor 8.1 | ISSN: 2581-3250 | CAS Source Indexed | Crossref DOI

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September 2026 - Vol. 36, Issue 3 

🌟 GSC Biological and Pharmaceutical Sciences (GSCBPS) 🌟

Low Publication Charges | Fast Editorial Processing | Crossref DOI Linking | Transparent Peer-Review Process

Publishing quality research in Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare and Allied Life Sciences.

e-ISSN: 2581-3250 | Impact Factor: 8.1 | Established: 2017 | Charges: USD 35 / INR 2100

📄 Submit Manuscript 👉 Author Guidelines 📚 Published Articles 

Quantitative structure-activity relationship study on the MMP-13 inhibitory activity of fused pyrimidine derivatives possessing a 1,2,4-Triazol-3-yl group as a ZBG

Breadcrumb

  • Home
  • Quantitative Structure-activity Relationship Study On The MMP-13 Inhibitory Activity of Fused Pyrimidine Derivatives Possessing a 1,2,4-Triazol-3-yl Group As a ZBG
  • Quantitative structure-activity relationship study on the MMP-13 inhibitory activity of fused pyrimidine derivatives possessing a 1,2,4-Triazol-3-yl group as a ZBG

Afsar Jahan 1, Brij Kishore Sharma 1, * and Vishnu Dutt Sharma 2

1 Department of Chemistry, Government College Bundi-323 001 (Rajasthan), India.
2 Department of Shalya Tantra, Dr. SR Rajasthan Ayurved University Jodhpur-342 037 (Rajasthan), India.
 
Research Article
GSC Biological and Pharmaceutical Sciences, 2021, 16(01), 251–265.
Article DOI: 10.30574/gscbps.2021.16.1.0199
DOI url: https://doi.org/10.30574/gscbps.2021.16.1.0199
Received on 09 June 2021; revised on 13 July 2021; accepted on 15 July 2021
 
QSAR study has been carried out on the MMP-13 inhibitory activity of fused pyrimidine derivatives possessing a1,2,4-triazol-3-yl group as a ZBG in 0D- to 2D-Dragon descriptors. The derived QSAR models have revealed that the number of Sulfur atoms (descriptor nS), Balaban mean square distance index (descriptor MSD), molecular electrotopological variation (descriptor DELS), structural information content index of neighborhood symmetry of 2nd and 3rd order (descriptors SIC2 and SIC3), average valence connectivity index chi-4 (descriptor X4Av) in addition to 1st order Galvez topological charge index (descriptor JGI1) and global topological charge index (descriptor JGT) played a pivotal role in rationalization of MMP-13 inhibition activity of titled compounds. Atomic properties such as mass and volume in terms of atomic properties weighted descriptors MATS5m and MATS3v, and certain atom centred fragments such as CH2RX (descriptor C-006), X--CX--X (descriptor C-044), H attached to heteroatom (descriptor H-050) and H attached to C0(sp3) with 1X attached to next C (descriptor H-052) are also predominant to explain MMP-13 inhibition actions of fused pyrimidines.
PLS analysis has also corroborated the dominance of CP-MLR identified descriptors. Applicability domain analysis revealed that the suggested model matches the high-quality parameters with good fitting power and the capability of assessing external data and all of the compounds was within the applicability domain of the proposed model and were evaluated correctly.
 
QSAR; MMP-13 inhibitory activity; Combinatorial protocol in multiple linear regression (CP-MLR) analysis; PLS analysis; Dragon descriptors; Fused pyrimidines; Zinc binding group (ZBG)
 
https://gscbps.gsconlinepress.com/sites/default/files/fulltext_pdf/GSCBPS-2021-…

Preview Article PDF

Afsar Jahan, Brij Kishore Sharma and Vishnu Dutt Sharma. Quantitative structure-activity relationship study on the MMP-13 inhibitory activity of fused pyrimidine derivatives possessing a 1,2,4-Triazol-3-yl group as a ZBG. GSC Biological and Pharmaceutical Sciences, 2021, 16(1), 251-265. Article DOI: https://doi.org/10.30574/gscbps.2021.16.1.0199


📝 Copyright, Licensing and Permissions: © Copyright Author(s). This article is published under the 🌐 Creative Commons Attribution 4.0 International License (CC BY 4.0) , which permits unrestricted use, distribution, adaptation, and reproduction in any medium, provided the original author(s) and source are properly credited, a link to the license is provided, and any changes made are indicated.


⚠️ Disclaimer: The statements, opinions, interpretations, and data presented in this publication are solely those of the individual author(s). GSC Biological and Pharmaceutical Sciences (GSCBPS), the editors, reviewers, editorial board, and publisher disclaim responsibility for any errors, omissions, or consequences arising from the use of the information contained in this article.


🏆 Get Publication Certificate 📄 Download Letter of Acceptance 🔗 Verify Crossref DOI 📘 View Issue Cover Page 👨‍🔬 Editorial Board 📑 Table of Contents 

🚀 Publish Your Research in International Peer Reviewed Open Access Journal - GSC Biological and Pharmaceutical Sciences (GSCBPS)

Submit your manuscripts from Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare, Biotechnology and Allied Life Sciences etc.

🌍 International Journal   |   👨‍🔬 Transparent Peer Review Process   |   🌐 Open Access Publishing   |   🔗 Crossref DOI 
⚡ Fast Editorial Processing   |   💰 Low Publication Charges

📝 Submit Your Manuscript 📘 Author Guidelines 💰 Publication Charges 

✅ No Submission Fee •  📜 Free Publication Certificate • 🌍 Global Visibility

⭐ Popular Pages


  • 🌍 International Journal
  • 🌐 Open Access Journal
  • 👨‍⚖️ Peer-Reviewed Journal
  • 💰 Low APC Journal
  • 🚀 Fast Publication Journal
  • ⚡ Fast-Track Peer-Review
  • 🔗 Crossref DOI Journal
  • 📖 Refereed Journal
  • 📈 High Impact Journal
  • 🧬 International Biology Journal
  • 💊 International Pharmacy Journal
  • 📝 Publish Research Paper

✍️ Author Resources


  • 📝 Publish Research Paper
  • 📖 Author Guidelines
  • 🎯 Aims and Scope
  • 💳 Article Processing Charges
  • 📤 Submit Manuscript
  • 📄 Cover Letter
  • ✍️ Author Declaration Form
  • 📄Track Manuscript Status
  • 📜 Get Publication Certificate
  • 📚 Journal Past Issue Archive
  • 🔎 Journal Indexing

⚖️ Journal Policies


  • ⚖️ Publication Ethics
  • 🛡️ Plagiarism Policy
  • 👨‍🔬 Peer Review Policy
  • 👨‍⚖️ Peer Review Process
  • 📖 Open Access Publishing
  • 📜 Copyright & Licensing
  • 🔗Author Self-Archiving Policy
  • 👥 Authorship Policy
  • 📊 Data Sharing Policy
  • 🤖 AI Usage Policy

Copyright © 2026 GSC Biological and Pharmaceutical Sciences - All rights reserved

Developed & Designed by VS Infosolution